Argentina

Argentina: back to a growing OTC and Rx market 

Argentina’s OTC and Rx market has experienced a big growth over the past few years and is offering golden opportunities. 

Argentina’s OTC and pharma market was worth US$ 3,9 billion in 2014. In recent years, Argentina has been suffering from a local economic crisis. However, the consumer health and pharma industry seems to have improved in the past two years and is expected to reach USD 7,5 billion in ex-factory by 2035, according to our CPC estimates. This growth will depend largely on the general economic situation of the country. 

There are three main players that make up the insurance system in Argentina: 

• The Argentinian government covers 36% of the population, supporting vaccines, primary care, medicines, clinical studies, hospitalization, and surgery. 
• Obras Sociales, the union-backed health insurance for workers, co-financed by employers and employees, covers 64% of the population. 
• Prepago is private health insurance that covers 13% of the population. 

Due to the recent economic environment in Argentina, the CONETEC (National Commission for the Evaluation of Health Technologies) was created in 2018 to carry out evaluations and issue recommendations to the health authority on the incorporation, form of use, financing, and coverage policies of health technologies.

At Chameleon Pharma Consulting Group, we support market entry for clients through consulting on Regulatory topics, GMP Certificates, and Market Entry Scenarios. Contact us for more details!